Aesculap recalls specific surgical instruments due to potential insufficient sterilization in certain batches. Affected instruments may pose infection risks during procedures.
“Aesculap CAIMAN Surgical Instrument Recall: Sterility Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/67249-aesculap-caiman-surgical-instrument-recall-sterility-risk. Based on FDA recall #Z-2496-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2496-2019%22&limit=1).
Aesculap Implant Systems LLC voluntarily recalled CAIMAN DISP.INSTR.ARTICULAT.D:12/240MM surgical instruments due to potential insufficient sterilization, the FDA said on Aug. 7, 2019.
The recall addresses the possibility that the sterility batch was insufficiently sterilized.
Context
GovInfoNow's records show Aesculap Implant Systems LLC has 26 other recalls on record since Aug. 10, 2017. Other recent recalls of similar products include Medline Surgical Packs Recall (Jan. 7, 2026), Vortex Surgical 25GA Subretinal Injection Cannula Recall (Dec. 16, 2025) and Arrowhead Implant Recall (June 23, 2026).
How to tell if you have this one
Check for the model 'CAIMAN DISP.INSTR.ARTICULAT.D:12/240MM' with reference number PL730SU. Affected lots are 109C and 837B.
Brand
Aescul: Aesculap Implant Systems LLC
Category
Medical device
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
US Nationwide distribution in the state of CA.
Recall number
Product, codes & lots
Quantity
Z-2496-2019
CAIMAN DISP.INSTR.ARTICULAT.D:12/240MM REF: PL730SU - Product Usage: Instrument intended for use in general surgery and gynecologic procedures where ligation and division of vessels is desired.; Lot # 109C and 837B
3 unit of Lot 837B
Z-2497-2019
CAIMAN DISP.INSTR.ARTICULAT.D:12/440MM REF: PL731SU- Product Usage: Instrument intended for use in general surgery and gynecologic procedures where ligation and division of vessels is desired.; Lot # 823B
0
Based on the official FDA remedy
What to do — step by step
Check Instrument Lot Number
Look for the lot numbers 109C or 837B on the instrument packaging or label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide distribution in the state of CA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2496-2019 (August 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2496-2019 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.